Kecheng Li - 16 May 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 May 2025, 19:06:28 UTC
Prior SEC filing
26 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jerome Wong, as Attorney-in-Fact

Key filing fact

Kecheng Li filed Form 4 for EKSO BIONICS HOLDINGS, INC. (EKSO) on 19 May 2025.

Key facts

  • This page summarizes Kecheng Li's Form 4 filing for EKSO BIONICS HOLDINGS, INC. (EKSO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 May 2025, 19:06.

Change

  • Previous filing in this sequence was filed on 26 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001735083 Primary reporting owner

Li Kecheng

Relationship
Director
Address
101 GLACIER POINT, SUITE A, SAN RAFAEL
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Signature date
19 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EKSO transaction

Common Stock

Award

Transaction value
$0
Shares
+236,202
Change %
+105%
Price
$0.000000
Shares after
460,940
Date
16 May 2025
Ownership
Direct
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

Footnote F2

This award of RSUs was granted effective May 16, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.

Footnote F3

Includes 236,202 unvested RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .